JMM Correspondence
Phospholipid catabolism by gut microbiota and the risk of cardiovascular disease
The role of phospholipids in the development of cardiovascular disease (CVD) is unclear, in contrast to current knowledge about triglycerides and lipoproteins. To address this gap in our knowledge, a study by Wang et al. (2011) described a metabolomic analysis of serum samples from human CVD patients using liquid chromatography-mass spectrometry (LC-MS), and identified trimethylamine N-oxide (TMAO), a choline metabolite, as a possible marker of the risk of developing CVD.
Phosphatidylcholine (PC), a major component of both plant and animal plasma membranes and especially abundant in foods such as fish, eggs and milk, is a major dietary source of choline, which is converted to trimethylamine (TMA) by the microflora. TMA is converted to TMAO by at least one liver enzyme [hepatic flavin-containing monooxygenase 3 (FMO3)]. Wang et al. (2011) noted that when apolipoprotein Edeficient (Apoe 2/2 ) mice, which are prone to develop atherosclerosis, were fed a normal diet (control group) or a cholineenriched diet (experimental group), the latter group, as expected, developed atherosclerotic symptoms. Interestingly, administering broad-spectrum antibiotics to Apoe 2/2 mice in the experimental group prior to choline feeding counteracted this effect. It was therefore suggested that the catabolism of PC by the gut microbiota could increase the risk of developing CVD. However, the study did not indicate what bacterial effectors could be responsible for the production of choline from dietary PC. It has been suggested that bacterial phospholipase D (PLD), which can directly hydrolyse PC to phosphatidic acid and choline, could be this effector (Loscalzo, 2011) , but the genes encoding such enzymes in the gut microbiota remain unidentified.
Bacteroidetes and Firmicutes are the predominant microbial phyla found in the human intestine (Eckburg et al., 2005) . Of the Bacteroidetes, it is known that Bacteroides fragilis and Bacteroides thetaiotaomicron (Gram-negative anaerobes) are the predominant species, with the latter being chosen as a model symbiont in studies investigating hostmicrobiota interactions (Moore & Holdeman, 1974; Xu & Gordon, 2003) . The genomes of both species have been sequenced, and are predicted to encode several putative phospholipases that may be assigned to one of two categories -the PLD and the patatin-like phospholipase families (see Table 1 ).
Early biochemical studies indicated that both B. thetaiotaomicron and B. fragilis exhibit phospholipase activity (James & Robinson, 1975) , though the underlying genes remain unknown. The PLD-like enzymes (Table 1 ) contain two HKD domains that are shared by other members of the PLD family such as cardiolipin synthases, phosphatidylserine synthases and some endonucleases and helicases (Ponting & Kerr, 1996) . Note that the enzymes listed in this category in Table 1 (Sitaraman et al., 2012) . This indicates that HP0190 homologues, in the tested strains at least, may possess membrane-damaging (lipolytic) activity.
The phospholipases containing patatin motifs are expected to exhibit phospholipase A activity based on precedent. Similar enzymes are also encoded by several species of pathogenic bacteria (Banerji & Flieger, 2004) . For example, the enzyme PatD expressed by Legionella pneumophila exhibits lysophospholipase A and phospholipase A activities (Aurass et al., 2009). The ExoU cytotoxin of Pseudomonas aeruginosa is known to possess both lipase and phospholipase A2 activities (Sato et al., 2003) . However, a product of phospholipase A activity on PC speciesglycerophosphorylcholine diester -could subsequently serve as a substrate for microbial glycerophosphoryl diester phosphodiesterases (GDPDs), releasing choline. Putative GDPDs in the genomes of B. thetaiotaomicron and B. fragilis have also been identified and annotated (see Table 1 ).
Admittedly, this list is only a tentative one that is unlikely to be either definitive or complete, given the paucity of specific experimental data from Bacteroides with regard to lipases/phospholipases. It may, however, serve as a starting point in a search for bacterial effectors that could influence host phospholipid profiles. In the light of the foregoing account, the mouse model developed by Wang et al. (2011) , i.e. germfree Apoe 2/2 mice, affords experimenters the opportunity to test the functionality of putative bacterial effectors by using B. thetaiotaomicron strains that are mutated in one or more of the genes listed in Table 1 . Then, mice colonized with mutant strains of B. thetaiotaomicron should exhibit reduced plasma TMAO levels, compared to those infected with the wild-type strain.
It is likely that Bacteroides enzymes hydrolyse dietary PC, contributing to the total choline/TMA load in the host. By the same token, ectopic and chronic expression of phospholipases by pathogens could be one of mechanisms underlying the apparent association of CVD with certain chronic infections with certain pathogens such as Helicobacter pylori (Patel et al., 1995; Kountouras et al., 2011) , Chlamydia species (Saikku et al., 1988; Patel et al., 1995) and cytomegalovirus (Epstein et al., 1996) . Specific inhibitors of bacterial phospholipases, preferably nonabsorbable through the gut, might alleviate excess TMAO levels, at least in the shortterm. 
